Chief Investigator of the MRC Myeloma IX Study
Clinical Trials and Research Unit
University of Leeds
IMF Scientific Advisory Board
While an undergraduate, he won the Leslie Hillman prize in haematology and was a Nutfield Traveling Scholar in Hong Kong, 1962. He qualified in 1963 and held several junior appointments, including a junior lectureship in Haematology at Guy's hospital.
He was a Medical Research Fellow at St. Bartholomew's Hospital, London (1968-1971) and subsequently Lecturer in Haematology at St. Bartholomew's.
Appointed Consultant Haematologist at The General Infirmary at Leeds, Yorkshire, UK in 1974, he has held a number of offices including Chairman of Faculty and Chairman of Executive Team, Steering Committee and Policy Committee of the Yorkshire Regional Cancer Organization.
He is a member of the medical Research Council Adult Leukaemia Trials Working Party and serves on the Sub-Groups for Chronic Lymphocyte Leukemia and Multiple Myeloma. He is the coordinator of the coordinator of the current MRC Myeloma VII Trial. He has also been closely involved with the UK national collaborate studies and trials in Hodgkin's disease and non-Hodgkin's Lymphoma throughout the UK and Central and Southern Lymphoma Groups.
His particular research interests have been in the investigation and treatment of the lymphoproliferative disorders and he has published extensively on this. The latest opus, with co-author colleagues Andrew Jack and Gareth Morgan, is "The Lymphoproliferative Disorders" (Chapman and Hull Medical, 1998) covering the diagnosis, investigation and management of this spectrum of the disease, embracing leukaemias, Hodgkins disease and other lymphomas and multiple myeloma.
With the late Teddy Cooper, Professor of Cancer Research in the University of Leeds, he carried out some of the first in-depth studies of beta-2-microglobulin (a key prognostic factor) in a range of disorders, including multiple myeloma and chronic lymphocytic leukaemia. In recent years, he has contributed in the bring together of a group of researchers, several of whom are engaged in the investigation of the myeloma cell and the molecular and cellular changes which occur following various treatment approaches.
As a clinician, he heads up and co-ordinates a busy clinical haematology service, principally for the haematological malignancies, with a particular emphasis on the development of innovative and intensive therapy.
He has a strong interest in promoting more effective collaborative working between specialist centres and has convened and chaired the newly-formed UK Myeloma Forum, intended to promote good practice and laboratory and clinical research.
At a personal level, he has been happily married for over 23 years and has three children- two girls, Chloé and Sarah, and a boy, Thomas. Chloé is a third year medical student at Edinburgh University Medical School.
His other interests include music, theatre, gardening, walking, skiing, and cricket (now only as coach of a local junior cricket team!). IMF Scientific Advisory Board